ecrin-mdr-crcClinical2015OxaliplatinPeripheral Nervous System DiseasesColorectal neoplasmsOxaliplatinColorectal cancerGastric cancerBiliary tract cancerPancreatic cancerBiliary tract neoplasmsStomach neoplasmsPancreatic neoplasmsOxaliplatinPeripheral Nervous System DiseasesBiliary Tract NeoplasmsColorectal NeoplasmsOxaliplatincolorectal Cancergastric Cancerbiliary Tract Cancerpancreatic CancerPancreatic NeoplasmsStomach NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2565376Thailand7ECRIN MDRRecruitingfalsePhase II Trial of capsaicin gel application for prevent oxaliplatin-induced peripheral neuropathyInterventions: 0.025% w/w Capsaicin gel;Experimental Drug;Capsaicin gel Primary outcome(s): Grade D or more peripheral neuropathy - free rate (From Grade A to E) 4 weeks after last dose of chemotherapy Patient Neurotoxicity Questionnaire (Thai version) Study Design: Non-randomized2015-07-152565376TCTR20150720002